Relapse to drug use after prolonged abstinence is the key impediment to successful treatment of drug addiction (Wikler, 1973; Jaffe, 1990). It has been known for many years that during abstinence exposure to cues and contexts previously associated with the rewarding effects of drugs can provoke relapse to drug use (Wikler, 1973; O'Brien et al., 1992). Relapse to drug use during abstinence has been the focus of preclinical studies for over 30 years (Stewart and de Wit, 1987). The abstinence period preceding relapse testing in studies using animal models is typically experimenter-imposed or forced; this is achieved either by removal of the laboratory animal from the drug self-administration environment or through extinction training (Shalev et al., 2002; Shaham et al., 2003). However, in humans abstinence is often voluntary due to either the negative consequences of chronic drug use or the presence of alternative non-drug rewards (Katz and Higgins, 2003; Epstein et al., 2006) Based on these considerations, the aim of my thesis was twofold: (1) to develop an animal model of relapse to drug seeking, which incorporates some aspects of the voluntary abstinence, and (2) to explore the neuronal mechanisms underlying this form of relapse. Based on recent studies of Ahmed and colleagues (Lenoir et al., 2007; Cantin et al., 2010; Ahmed et al., 2013b), we first investigated how to achieve voluntary abstinence in rats. We found that by using a mutually exclusive discrete choice procedure, rats voluntarily abstain from methamphetamine because of the presence of a non-drug reward (high carbohydrate palatable food pellets). Indeed, independently of the daily drug access conditions and the withdrawal period, the rats strongly preferred palatable food over methamphetamine, even when they were given free access to the palatable food in the home cage (Caprioli et al., 2015a). Subsequently, we used this choice procedure to develop a rat model of incubation of drug craving in which abstinence is achieved voluntarily (Caprioli et al., 2015b). In this model, we first train rats with free access to ‘animal facility’ nutritionally-balanced food to self-administer palatable food pellets and then to self-administer intravenous methamphetamine. Next, we assess cue-induced methamphetamine seeking in extinctions test during early (day 1) and late (day 14 or 21) abstinence. Between tests, the rats undergo voluntary abstinence in their drug environment; this is achieved via a discrete choice procedure between methamphetamine and palatable food. In this model, cue-induced methamphetamine seeking is higher after 21 abstinence days than after 1 day (incubation of methamphetamine craving). Using this animal model we showed a robust incubation of methamphetamine craving after prolonged periods of choice-based voluntary abstinence (Caprioli et al., 2015b). This effect was observed under two different self-administration procedures that are widely used to model drug addiction: extended daily access drug self-administration procedure (Ahmed and Koob, 1998; Ahmed, 2011) and a long-term training procedure used to identify addicted rats based on DSM-IV criteria (Deroche-Gamonet et al., 2004; Piazza and Deroche-Gamonet, 2013) A question that derives from our study is whether similar or different neurobiological mechanisms control incubation of methamphetamine craving after voluntary versus forced abstinence. For this purpose, we used AZD8529, a new and highly selective positive allosteric modulator (PAM) of metabotropic glutamate receptor 2 (mGluR2) (Justinova et al., 2015). AZD8529 had a similar effect on incubated cue-induced methamphetamine seeking after voluntary and forced abstinence, suggesting mechanistic similarities (Caprioli et al., 2015b). An important question moving forward was which neural mechanisms are critical for the relapse triggered by drug-associated cues after voluntary abstinence. To address this question, we used the neuronal activity marker Fos (Curran and Morgan, 1995) and local dopamine receptor blockade and demonstrated a critical role of central amygdala (CeA) in cue-induced methamphetamine seeking after voluntary abstinence. Moreover, in our follow-up tracing study we used the retrograde tracer cholera toxin subunit b (CTb) in combination with Fos and identified a selective activation of the anterior insula (AI) to CeA projection in this form of relapse. These results are consistent with human imaging studies showing that cue-induced cocaine craving is associated with insula and amygdala activation (Grant et al., 1996; Garavan et al., 2000) and that cue-induced methamphetamine craving is associated with insula activation (Yin et al., 2012).

Relapse to drug use after prolonged abstinence is the key impediment to successful treatment of drug addiction (Wikler, 1973; Jaffe, 1990). It has been known for many years that during abstinence exposure to cues and contexts previously associated with the rewarding effects of drugs can provoke relapse to drug use (Wikler, 1973; O'Brien et al., 1992). Relapse to drug use during abstinence has been the focus of preclinical studies for over 30 years (Stewart and de Wit, 1987). The abstinence period preceding relapse testing in studies using animal models is typically experimenter-imposed or forced; this is achieved either by removal of the laboratory animal from the drug self-administration environment or through extinction training (Shalev et al., 2002; Shaham et al., 2003). However, in humans abstinence is often voluntary due to either the negative consequences of chronic drug use or the presence of alternative non-drug rewards (Katz and Higgins, 2003; Epstein et al., 2006) Based on these considerations, the aim of my thesis was twofold: (1) to develop an animal model of relapse to drug seeking, which incorporates some aspects of the voluntary abstinence, and (2) to explore the neuronal mechanisms underlying this form of relapse. Based on recent studies of Ahmed and colleagues (Lenoir et al., 2007; Cantin et al., 2010; Ahmed et al., 2013b), we first investigated how to achieve voluntary abstinence in rats. We found that by using a mutually exclusive discrete choice procedure, rats voluntarily abstain from methamphetamine because of the presence of a non-drug reward (high carbohydrate palatable food pellets). Indeed, independently of the daily drug access conditions and the withdrawal period, the rats strongly preferred palatable food over methamphetamine, even when they were given free access to the palatable food in the home cage (Caprioli et al., 2015a). Subsequently, we used this choice procedure to develop a rat model of incubation of drug craving in which abstinence is achieved voluntarily (Caprioli et al., 2015b). In this model, we first train rats with free access to ‘animal facility’ nutritionally-balanced food to self-administer palatable food pellets and then to self-administer intravenous methamphetamine. Next, we assess cue-induced methamphetamine seeking in extinctions test during early (day 1) and late (day 14 or 21) abstinence. Between tests, the rats undergo voluntary abstinence in their drug environment; this is achieved via a discrete choice procedure between methamphetamine and palatable food. In this model, cue-induced methamphetamine seeking is higher after 21 abstinence days than after 1 day (incubation of methamphetamine craving). Using this animal model we showed a robust incubation of methamphetamine craving after prolonged periods of choice-based voluntary abstinence (Caprioli et al., 2015b). This effect was observed under two different self-administration procedures that are widely used to model drug addiction: extended daily access drug self-administration procedure (Ahmed and Koob, 1998; Ahmed, 2011) and a long-term training procedure used to identify addicted rats based on DSM-IV criteria (Deroche-Gamonet et al., 2004; Piazza and Deroche-Gamonet, 2013) A question that derives from our study is whether similar or different neurobiological mechanisms control incubation of methamphetamine craving after voluntary versus forced abstinence. For this purpose, we used AZD8529, a new and highly selective positive allosteric modulator (PAM) of metabotropic glutamate receptor 2 (mGluR2) (Justinova et al., 2015). AZD8529 had a similar effect on incubated cue-induced methamphetamine seeking after voluntary and forced abstinence, suggesting mechanistic similarities (Caprioli et al., 2015b). An important question moving forward was which neural mechanisms are critical for the relapse triggered by drug-associated cues after voluntary abstinence. To address this question, we used the neuronal activity marker Fos (Curran and Morgan, 1995) and local dopamine receptor blockade and demonstrated a critical role of central amygdala (CeA) in cue-induced methamphetamine seeking after voluntary abstinence. Moreover, in our follow-up tracing study we used the retrograde tracer cholera toxin subunit b (CTb) in combination with Fos and identified a selective activation of the anterior insula (AI) to CeA projection in this form of relapse. These results are consistent with human imaging studies showing that cue-induced cocaine craving is associated with insula and amygdala activation (Grant et al., 1996; Garavan et al., 2000) and that cue-induced methamphetamine craving is associated with insula activation (Yin et al., 2012).

Neural mechanisms of relapse to methamphetamine seeking after voluntary abstinence in a rat model

Venniro, Marco
2016-01-01

Abstract

Relapse to drug use after prolonged abstinence is the key impediment to successful treatment of drug addiction (Wikler, 1973; Jaffe, 1990). It has been known for many years that during abstinence exposure to cues and contexts previously associated with the rewarding effects of drugs can provoke relapse to drug use (Wikler, 1973; O'Brien et al., 1992). Relapse to drug use during abstinence has been the focus of preclinical studies for over 30 years (Stewart and de Wit, 1987). The abstinence period preceding relapse testing in studies using animal models is typically experimenter-imposed or forced; this is achieved either by removal of the laboratory animal from the drug self-administration environment or through extinction training (Shalev et al., 2002; Shaham et al., 2003). However, in humans abstinence is often voluntary due to either the negative consequences of chronic drug use or the presence of alternative non-drug rewards (Katz and Higgins, 2003; Epstein et al., 2006) Based on these considerations, the aim of my thesis was twofold: (1) to develop an animal model of relapse to drug seeking, which incorporates some aspects of the voluntary abstinence, and (2) to explore the neuronal mechanisms underlying this form of relapse. Based on recent studies of Ahmed and colleagues (Lenoir et al., 2007; Cantin et al., 2010; Ahmed et al., 2013b), we first investigated how to achieve voluntary abstinence in rats. We found that by using a mutually exclusive discrete choice procedure, rats voluntarily abstain from methamphetamine because of the presence of a non-drug reward (high carbohydrate palatable food pellets). Indeed, independently of the daily drug access conditions and the withdrawal period, the rats strongly preferred palatable food over methamphetamine, even when they were given free access to the palatable food in the home cage (Caprioli et al., 2015a). Subsequently, we used this choice procedure to develop a rat model of incubation of drug craving in which abstinence is achieved voluntarily (Caprioli et al., 2015b). In this model, we first train rats with free access to ‘animal facility’ nutritionally-balanced food to self-administer palatable food pellets and then to self-administer intravenous methamphetamine. Next, we assess cue-induced methamphetamine seeking in extinctions test during early (day 1) and late (day 14 or 21) abstinence. Between tests, the rats undergo voluntary abstinence in their drug environment; this is achieved via a discrete choice procedure between methamphetamine and palatable food. In this model, cue-induced methamphetamine seeking is higher after 21 abstinence days than after 1 day (incubation of methamphetamine craving). Using this animal model we showed a robust incubation of methamphetamine craving after prolonged periods of choice-based voluntary abstinence (Caprioli et al., 2015b). This effect was observed under two different self-administration procedures that are widely used to model drug addiction: extended daily access drug self-administration procedure (Ahmed and Koob, 1998; Ahmed, 2011) and a long-term training procedure used to identify addicted rats based on DSM-IV criteria (Deroche-Gamonet et al., 2004; Piazza and Deroche-Gamonet, 2013) A question that derives from our study is whether similar or different neurobiological mechanisms control incubation of methamphetamine craving after voluntary versus forced abstinence. For this purpose, we used AZD8529, a new and highly selective positive allosteric modulator (PAM) of metabotropic glutamate receptor 2 (mGluR2) (Justinova et al., 2015). AZD8529 had a similar effect on incubated cue-induced methamphetamine seeking after voluntary and forced abstinence, suggesting mechanistic similarities (Caprioli et al., 2015b). An important question moving forward was which neural mechanisms are critical for the relapse triggered by drug-associated cues after voluntary abstinence. To address this question, we used the neuronal activity marker Fos (Curran and Morgan, 1995) and local dopamine receptor blockade and demonstrated a critical role of central amygdala (CeA) in cue-induced methamphetamine seeking after voluntary abstinence. Moreover, in our follow-up tracing study we used the retrograde tracer cholera toxin subunit b (CTb) in combination with Fos and identified a selective activation of the anterior insula (AI) to CeA projection in this form of relapse. These results are consistent with human imaging studies showing that cue-induced cocaine craving is associated with insula and amygdala activation (Grant et al., 1996; Garavan et al., 2000) and that cue-induced methamphetamine craving is associated with insula activation (Yin et al., 2012).
2016
Choice, Drugs, Abstinence, Neuroscience
Relapse to drug use after prolonged abstinence is the key impediment to successful treatment of drug addiction (Wikler, 1973; Jaffe, 1990). It has been known for many years that during abstinence exposure to cues and contexts previously associated with the rewarding effects of drugs can provoke relapse to drug use (Wikler, 1973; O'Brien et al., 1992). Relapse to drug use during abstinence has been the focus of preclinical studies for over 30 years (Stewart and de Wit, 1987). The abstinence period preceding relapse testing in studies using animal models is typically experimenter-imposed or forced; this is achieved either by removal of the laboratory animal from the drug self-administration environment or through extinction training (Shalev et al., 2002; Shaham et al., 2003). However, in humans abstinence is often voluntary due to either the negative consequences of chronic drug use or the presence of alternative non-drug rewards (Katz and Higgins, 2003; Epstein et al., 2006) Based on these considerations, the aim of my thesis was twofold: (1) to develop an animal model of relapse to drug seeking, which incorporates some aspects of the voluntary abstinence, and (2) to explore the neuronal mechanisms underlying this form of relapse. Based on recent studies of Ahmed and colleagues (Lenoir et al., 2007; Cantin et al., 2010; Ahmed et al., 2013b), we first investigated how to achieve voluntary abstinence in rats. We found that by using a mutually exclusive discrete choice procedure, rats voluntarily abstain from methamphetamine because of the presence of a non-drug reward (high carbohydrate palatable food pellets). Indeed, independently of the daily drug access conditions and the withdrawal period, the rats strongly preferred palatable food over methamphetamine, even when they were given free access to the palatable food in the home cage (Caprioli et al., 2015a). Subsequently, we used this choice procedure to develop a rat model of incubation of drug craving in which abstinence is achieved voluntarily (Caprioli et al., 2015b). In this model, we first train rats with free access to ‘animal facility’ nutritionally-balanced food to self-administer palatable food pellets and then to self-administer intravenous methamphetamine. Next, we assess cue-induced methamphetamine seeking in extinctions test during early (day 1) and late (day 14 or 21) abstinence. Between tests, the rats undergo voluntary abstinence in their drug environment; this is achieved via a discrete choice procedure between methamphetamine and palatable food. In this model, cue-induced methamphetamine seeking is higher after 21 abstinence days than after 1 day (incubation of methamphetamine craving). Using this animal model we showed a robust incubation of methamphetamine craving after prolonged periods of choice-based voluntary abstinence (Caprioli et al., 2015b). This effect was observed under two different self-administration procedures that are widely used to model drug addiction: extended daily access drug self-administration procedure (Ahmed and Koob, 1998; Ahmed, 2011) and a long-term training procedure used to identify addicted rats based on DSM-IV criteria (Deroche-Gamonet et al., 2004; Piazza and Deroche-Gamonet, 2013) A question that derives from our study is whether similar or different neurobiological mechanisms control incubation of methamphetamine craving after voluntary versus forced abstinence. For this purpose, we used AZD8529, a new and highly selective positive allosteric modulator (PAM) of metabotropic glutamate receptor 2 (mGluR2) (Justinova et al., 2015). AZD8529 had a similar effect on incubated cue-induced methamphetamine seeking after voluntary and forced abstinence, suggesting mechanistic similarities (Caprioli et al., 2015b). An important question moving forward was which neural mechanisms are critical for the relapse triggered by drug-associated cues after voluntary abstinence. To address this question, we used the neuronal activity marker Fos (Curran and Morgan, 1995) and local dopamine receptor blockade and demonstrated a critical role of central amygdala (CeA) in cue-induced methamphetamine seeking after voluntary abstinence. Moreover, in our follow-up tracing study we used the retrograde tracer cholera toxin subunit b (CTb) in combination with Fos and identified a selective activation of the anterior insula (AI) to CeA projection in this form of relapse. These results are consistent with human imaging studies showing that cue-induced cocaine craving is associated with insula and amygdala activation (Grant et al., 1996; Garavan et al., 2000) and that cue-induced methamphetamine craving is associated with insula activation (Yin et al., 2012).
File in questo prodotto:
File Dimensione Formato  
Venniro Dissertation.pdf

non disponibili

Descrizione: Tesi di dottorato
Tipologia: Tesi di dottorato
Licenza: Creative commons
Dimensione 2.39 MB
Formato Adobe PDF
2.39 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/939027
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact